Advisory on the Use of RT-PCR Testing Kits for COVID-19 Manufactured by Manila HealthTek, Inc.
The Department of Health (DOH) issued Department Circular No. 2020-0194, advising that the GenAmplify COVID-19 rRT-PCR Detection Kit from Manila HealthTek, Inc. can only be utilized after receiving a positive recommendation from the Research Institute for Tropical Medicine (RITM) based on performance validation. The DOH will inform relevant parties once the RITM releases the validation results for this testing kit. This directive emphasizes the importance of compliance with the established protocols for COVID-19 testing.
Law Information
- Reference Number
- DOH Department Circular No. 2020-0194
- Date Enacted
- Subcategory
- Department of Health
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
April 28, 2020
DOH DEPARTMENT CIRCULAR NO. 2020-0194
| TO | : | All Directors and Heads of Research Institute of Tropical Medicine, Sub-National Laboratories, Victoriano Memorial Medical Center, University of the Philippines-National Institutes for Health, and Philippine Genome Center |
| SUBJECT | : | Advisory on the Use of RT-PCR Testing Kits for COVID-19 Manufactured by Manila HealthTek, Inc. |
The Department of Health reiterates that GenAmplifyâ„¢ Corona Virus Disease-2019 (COVID-19) rRT-PCR Detection Kit manufactured by Manila HealthTek, Inc. shall be only used once the Research Institute for Tropical Medicine issues out positive recommendation from its performance validation.
The Department shall notify once RITM releases the results of the validation of the said RT-PCR testing kit for SARS-CoV-2.
For strict compliance.
By Authority of the Secretary of Health,
(SGD.) MARIA ROSARIO SINGH-VERGEIRE, MD, MPH, CESO IVOIC-Undersecretary
Cite This Law
Advisory on the Use of RT-PCR Testing Kits for COVID-19 Manufactured by Manila HealthTek, Inc., DOH Department Circular No. 2020-0194, Apr 28, 2020 (Philippines)
Advisory on the Use of RT-PCR Testing Kits for COVID-19 Manufactured by Manila HealthTek, Inc., DOH Department Circular No. 2020-0194 (Phil. 2020)
Related Laws
- Guidance on Use of COVID-19 Rapid Antibody-based Test KitsDOH Department Circular No. 2020-0160 • Mar 31, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Public Advisory No. 20 — COVID-19 Laboratory TestingDOH Department Circular No. 2020-0143 • Mar 19, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Clarification on the Financing and Reimbursement of COVID-19 Antibody Test Kits by the DOH and PhilHealth, RespectivelyDOH Department Circular No. 2020-0184 • Apr 9, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- List of Approved COVID-19 Test Kits for Commercial UseFDA Advisory No. 409-20 • Mar 19, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Varying Specifications and Use of COVID-19 Rapid Antibody Test KitsFDA Advisory No. 671-20 • Apr 18, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Funds for the Handling, Management, and Testing of Reported COVID-19 Cases and Close Contacts in the Central OfficeDepEd Tasked Force COVID-19 Memorandum No. 071-20 • Jul 22, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Browse More Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Explore other laws in the Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances category.
View All Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law